So when Mounjaro’s maker, Eli Lilly, sued Empower last month for selling “knockoff” versions, the Houston pharmacy portrayed the case as “Big Pharma testing its power” against companies ...

ELI LILLY SUIT: Eli Lilly targets Houston-based Empower Pharmacy over copycat diabetes, weight loss drugs There are other basic guardrails in place. State laws require a licensed pharmacist or ...

Eli Lilly also made waves locally this year for suing Houston-based Empower Pharmacy, alleging the company is selling knockoff versions of its weight-loss and diabetes medications.

Eli Lilly is evaluating a massive $5.9 billion biomanufacturing ... Meanwhile, the company is embroiled in a legal battle with Houston’s Empower Pharmacy over alleged copycat drugs, proving that ...

Eli Lilly (NYSE: LLY) is one of the undisputed leaders in developing anti-obesity medicines, with Novo Nordisk (NYSE: NVO) being its biggest challenger. Over the past six months, Eli Lilly has ...

President Donald Trump vowed to impose tariffs on pharmaceuticals within two weeks. Eli Lilly, a leader in the industry, could be harmed by the move, but it is already preparing for it.

Eli Lilly’s total deal value with Rznomics could exceed $1.3 billion, plus royalties. Rznomics will lead early-stage research; Lilly to handle development and sales. Get access to the ...

The head of drugmaker Eli Lilly, which sells the popular weight-loss drug Zepbound, urged the Trump administration to ease up on its tariff rollout because it could hurt Lilly’s business and the ...